Treatment of Helicobacter pylori in Special Patient Populations

CT Nguyen, KA Davis, SA Nisly… - … : The Journal of Human …, 2019 - Wiley Online Library
Helicobacter pylori infection can lead to gastritis, gastric and duodenal ulcers, and gastric
cancer. Consequently, complete eradication is the goal of therapy. First‐line therapy for H …

Optimal therapy for Helicobacter pylori infections

E Rimbara, LA Fischbach, DY Graham - … reviews Gastroenterology & …, 2011 - nature.com
Although Helicobacter pylori infection is both a common and a serious bacterial infection,
antimicrobial therapies have rarely been optimized, are prescribed empirically, and provide …

[HTML][HTML] Treatment of Helicobacter pylori infection: current status and future concepts

JC Yang, CW Lu, CJ Lin - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) infection is highly associated with the occurrence of
gastrointestinal diseases, including gastric inflammation, peptic ulcer, gastric cancer, and …

ACG clinical guideline: treatment of Helicobacter pylori infection

WD Chey, GI Leontiadis, CW Howden… - Official journal of the …, 2017 - journals.lww.com
Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important
cause of peptic ulcer disease and gastric cancer. H. pylorimay also have a role in …

Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic

G Treiber, P Malfertheiner, U Klotz - Expert opinion on …, 2007 - Taylor & Francis
Helicobacter pylori infection is a major cause of diseases located in the upper
gastrointestinal tract. Successful eradication of the bacteria may improve H. pylori-related …

Management of Helicobacter pylori infection

F Costa, MM D'Elios - Expert review of anti-infective therapy, 2010 - Taylor & Francis
Helicobacter pylori is the cause of peptic ulcer, gastric cancer and gastric lymphoma.
Diagnosis of H. pylori infection can be made using invasive and noninvasive tests. Invasive …

Clarithromycin for Helicobacter pylori infection

WK Leung, DY Graham - Expert opinion on pharmacotherapy, 2000 - Taylor & Francis
Helicobacter pylori, a Gram-negative organism that survives in the deep mucus layer and
attaches to the gastric surface cells, is estimated to be present in up to one-half of the US …

Treatment of Helicobacter pylori infection in clinical practice in the United States

DJ Kearney, A Brousal - Digestive diseases and sciences, 2000 - Springer
Our objectives were to define treatment success, compliance, and side effects for treatment
of Helicobacter pylori in clinical practice. In all, 224 consecutive patients received …

[HTML][HTML] Helicobacter pylori: management in 2013

YO Alahdab, C Kalayci - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is a prevalent, worldwide, chronic infection. Choice of
treatment can be modified according to antibiotic-resistance rates of H. pylori. The ideal …

Helicobacter pylori infection-current treatment practice

HHX Xia, BC Yu Wong, NJ Talley… - Expert Opinion on …, 2001 - Taylor & Francis
Helicobacter pylori infection, which is present in 30-60% of the population in developed
countries and in more than 60% in developing countries, is established to be a major cause …